Business: Phase 2 biotech targeting acute ischemic stroke and chronic ... Business: Preclinical biotech developing immunotherapies for solid tumors ...
News
- Initial public offerings scheduled to debut next week
- Fear that uproar over gene-edited babies could block science
But there's significant discomfort, if not complete opposition, to enhancement uses," said Josephine Johnston, an expert on biomedical ethics and ...
- US stocks rise before Trump-Xi trade meeting; oil slips
Biotech drugmaker AbbVie rose 3.8 percent to $93.35 after it said Pfizer agreed to wait until November 2023 before it starts selling a generic version of ...
- zSpace's Career Technical and Education Offering on AR/VR Platform Expands to Include ...
... and biomedical sciences industries. zSpace, an educational solution that combines elements of VR and AR on a specialized all-in-one computer or ...
- CytoBiosciences Buys Fellow Targeted Tech Company BioDTech for Stock
San Antonio-based CytoBioscience, through its parent company, is buying BioDtech, a Birmingham, AL-based maker of technology for detecting and ...